Publications by authors named "R Galot"

Claim this Profile
T
Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1 Inhibitor.
Natasha Honoré, George Laliotis, Vasily N Aushev, Sharlene Velichko, Charuta C Palsuledesai, Rachel Galot

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer.
Caroline Anthon, Hugo Pierret, Frederic Houssiau, Astrid De Cuyper, Cédric Van Marcke, Rachel Galot

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma.
Rachel Galot, Jean-Pascal H Machiels

Curr Opin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-informed ctDNA assay to predict recurrence in locally advanced squamous-cell carcinoma of the head and neck (SCCHN).
N Honoré, G Laliotis, V Aushev, S Velichko, C Palsuledesai, R Galot

ESMO Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
R Galot, C Le Tourneau, L Licitra, J Guigay, A Kong

ESMO Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis